The enteral feeding devices market is estimated to amass profitable gains through 2027 owing to the increasing demand for enteral nutrition among patients suffering from malnourishment, diseases that hinder oral intake, or undergoing post-surgery recovery, among other medical conditions.

After the COVID-19 outbreak, there was an upsurge in patients who had been infected and were in need of critical care. For such patients, enteral nutrition was recommended to be administered soon after they were admitted into intensive care units (ICUs).

Enteral feeding tubes viz., orogastric (OG) or larger bore nasogastric (NG) tubes were preferred for COVID-positive patients. Thus, the proliferating utilization of these devices during the pandemic has further impelled market expansion across the globe.

Moreover, industry players have also been adopting various strategies to augment their presence in the sector, which has significantly enhanced business outlook. For instance, in September 2020, ENvizion, a leading enteral feeding solutions provider, inked an agreement with the largest private hospital networks in the United States, which encompasses over one hundred hospitals, to offer its devices across the nation.

For comprehensive assessment, the enteral feeding devices market has been bifurcated based on product, patient, application, end-use, and region. In terms of product, the market has further been segmented into enteral feeding pumps, enteral feeding tubes, giving sets, enteral syringes, and accessories.

The enteral feeding pumps sub-segment holds a significant share in the overall market revenue and was valued at around USD 2,127 million in 2020. Surging adoption of enteral feeding therapy, coupled with growing incidences of chronic ailments across the globe, is projected to drive segmental growth over 2021-2027.

With respect to patient, the market has been segregated into adult and pediatric. The adult sub-segment valuation exceeded USD 3,063 million in 2020 and is speculated to observe profitable growth by the end of 2027. The expanding geriatric population base and mounting occurrences of medical conditions that make oral intake challenging for adults are anticipated to fuel segmental adoption through the following years.

From the application perspective, the market has been segmented into central nervous system (CNS) & mental health, cancer, non-malignant gastrointestinal (GI) disorders, and others. In 2020, the cancer sub-segment accounted for the lion's share of over 45% in the enteral feeding devices market and is estimated to progress at a robust pace over the forecast timeline. Growing prevalence of cancer, particularly head & neck, gastrointestinal, lung, and liver cancers, is likely to bolster product demand through the analysis period.

On the basis of end-use, the enteral feeding devices market has been categorized into hospital, home care, and others. The home care sub-segment is anticipated to witness lucrative growth to garner a sizable revenue of around USD 3,750 million by 2027. Rising adoption of enteral feeding devices in home care settings and surging need to curb the escalating healthcare expenses across the globe are likely to support market adoption across the home care segment in the future.

In the regional landscape, the Middle East & Africa enteral feeding devices market was valued at over USD 222 million in 2020 and is projected to observe significant growth through the analysis time period. Increasing number of people suffering from malnutrition and growing product adoption across various countries in the region are expected to foster market outlook through the forecast timeline.